Stem-cell therapy used to restore joint health – Brunswick News
Brunswick News |
Stem–cell therapy used to restore joint health
Brunswick News In a nutshell, stem–cell therapy can promote the body’s regrowth of cartilage, thereby decreasing joint pain. The National Institute of Health, a federal agency, reports stem–cell therapy “holds the promise of regenerating damaged tissues and organs in … |
TechnoChops (press release) (blog) |
Israeli scientists successfully treat cancer tumor using ‘nano-factory’ tech
TechnoChops (press release) (blog) The Israeli scientists successfully developed artificial cells or “nano-factories” that produce proteins from within the tissue, thereby battling cancer tumors. Details of the technique — tested in both lab cell cultures and in mice and found … |
UTSA Today |
Max and Minnie Tomerlin Voelcker Fund propels stem cell research at UTSA
UTSA Today With its generosity and belief in the power that science has to improve ordinary lives, the Voelcker Fund is aiding UTSA in bringing stem cell and regenerative medicine research to new heights. The fund’s support is advancing UTSA research to generate … |
pharmaphorum |
Groundbreaking lung cancer approval a big boost for AZ’s Imfinzi
pharmaphorum AstraZeneca’s immunotherapy Imfinzi has gained US approval in an important new earlier treatment setting for lung cancer patients. The company announced on Friday that the FDA had approved the drug’s use in patients with unresectable Stage III non … Astrazeneca shares bounce back after cancer drug approval …The Times US clears AZ’ Imfinzi for lung cancerPharmaTimes Dr. Schwartz on the Results of the PACIFIC TrialOncLive |
AzerNews |
Azerbaijan plans to create center of stem cells – AzerNews
AzerNews Azerbaijan is planning the formation of a new culture of health care for human beings, as academician-secretary of the Department of Biological and Medical Sciences of ANAS, academician Ahliman Amiraslanov said that it’s high time to create a center of … |
Nasdaq |
AstraZeneca’s immunotherapy drug wins key lung cancer approval
Nasdaq AstraZeneca still hopes to catch up in the advanced lung cancer market too, by combining Imfinzi with another immunotherapy drug called tremelimumab. Initial results from a clinical trial testing this combination proved disappointing last July, but the … Immunotherapy Drug Wins Key Lung Cancer OK | Newsmax.comNewsmax Astrazeneca shares bounce back after cancer drug approvalThe Times |